Surrozen, Inc.: COLUMN GROUP III GP, LP amends Schedule 13D stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Column Group III GP, LP amended its Schedule 13D filing on Surrozen, Inc. with the SEC (accession 0001193125-26-467393), updating its disclosed stake in the biotechnology company. The filing signals a change in the investor's position or intent regarding its holdings, a disclosure required of beneficial owners above 5% under SEC rules. Investors watch 13D amendments for signs of activist intent, stake changes, or governance influence at small-cap issuers like Surrozen. The specific revised ownership percentage and any stated purpose were not detailed in the headline.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13D's report. It can get details wrong, so check the source.
Named in this story
Surrozen, Inc., COLUMN GROUP III GP, LP